HSBC Holdings’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-16,115
| Closed | -$1.58M | – | 2704 |
|
|
2025
Q2 | $1.58M | Buy |
+16,115
| New | +$1.52M | ﹤0.01% | 1581 |
|
|
2024
Q3 | – | Sell |
-61,391
| Closed | -$5.65M | – | 2980 |
|
|
2024
Q2 | $5.65M | Sell |
61,391
-29,836
| -33% | -$2.77M | ﹤0.01% | 1027 |
|
|
2024
Q1 | $8.41M | Sell |
91,227
-19,352
| -18% | -$1.81M | 0.01% | 939 |
|
|
2023
Q4 | $10.5M | Buy |
110,579
+100
| +0.1% | +$9.34K | 0.01% | 877 |
|
|
2023
Q3 | $10.3M | Buy |
110,479
+71,705
| +185% | +$6.63M | 0.01% | 818 |
|
|
2023
Q2 | $3.54M | Buy |
38,774
+31,868
| +461% | +$2.61M | ﹤0.01% | 1200 |
|
|
2023
Q1 | $509K | Sell |
6,906
-8,652
| -56% | -$749K | ﹤0.01% | 2033 |
|
|
2022
Q4 | $1.29M | Buy |
15,558
+3,193
| +26% | +$288K | ﹤0.01% | 1855 |
|
|
2022
Q3 | $1.24M | Sell |
12,365
-7,778
| -39% | -$927K | ﹤0.01% | 1741 |
|
|
2022
Q2 | $2.14M | Buy |
20,143
+6,346
| +46% | +$811K | ﹤0.01% | 1555 |
|
|
2022
Q1 | $2.39M | Buy |
13,797
+3,999
| +41% | +$597K | ﹤0.01% | 1526 |
|
|
2021
Q4 | $1.6M | Sell |
9,798
-4,800
| -33% | -$771K | ﹤0.01% | 1790 |
|
|
2021
Q3 | $2.19M | Buy |
14,598
+10,855
| +290% | +$2.26M | ﹤0.01% | 1495 |
|
|
2021
Q2 | $913K | Buy |
3,743
+2,163
| +137% | +$568K | ﹤0.01% | 1815 |
|
|
2021
Q1 | $420K | Sell |
1,580
-939
| -37% | -$265K | ﹤0.01% | 2095 |
|
|
2020
Q4 | $731K | Buy |
2,519
+1,060
| +73% | +$272K | ﹤0.01% | 1924 |
|
|
2020
Q3 | $347K | Buy |
+1,459
| New | +$332K | ﹤0.01% | 2164 |
|
|
2020
Q2 | – | Sell |
-3,644
| Closed | -$668K | – | 2642 |
|
|
2020
Q1 | $668K | Sell |
3,644
-533
| -13% | -$94.8K | ﹤0.01% | 1637 |
|
|
2019
Q4 | $699K | Sell |
4,177
-106
| -2% | -$15.8K | ﹤0.01% | 2037 |
|
|
2019
Q3 | $560K | Sell |
4,283
-10,659
| -71% | -$1.39M | ﹤0.01% | 2269 |
|
|
2019
Q2 | $1.81M | Sell |
14,942
-11,937
| -44% | -$1.42M | ﹤0.01% | 1557 |
|
|
2019
Q1 | $3.31M | Buy |
26,879
+9,252
| +52% | +$1.16M | 0.01% | 1282 |
|
|
2018
Q4 | $2.06M | Buy |
17,627
+15,831
| +881% | +$1.87M | ﹤0.01% | 1485 |
|
|
2018
Q3 | $224K | Buy |
+1,796
| New | +$198K | ﹤0.01% | 2371 |
|
|
2017
Q1 | – | Sell |
-6,810
| Closed | -$290K | – | 2128 |
|
|
2016
Q4 | $290K | Buy |
+6,810
| New | +$290K | ﹤0.01% | 2259 |
|
Other funds holding AMED
IA
MCI
HNB
HSBC Holdings's AMED Position: Q3 2025 in Review
HSBC Holdings sold out of Amedisys (AMED) in Q3 2025, closing a stake of 16,115 shares — an estimated $1.58M sold.
HSBC Holdings first reported a position in AMED in Q4 2016 and held it in 25 quarters. The position peaked at $10.5M in Q4 2023. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.
- HSBC Holdings reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
- HSBC Holdings sold 16,115 Amedisys shares in Q3 2025, an estimated $1.58M.
- HSBC Holdings first reported a position in Amedisys in Q4 2016 and held it in 25 quarters.
- HSBC Holdings's Amedisys position peaked at $10.5M in Q4 2023.
- 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.
Based on HSBC Holdings's 13F filing for Q3 2025, filed 13 Nov 2025.